Gardasil Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Conditions:   Condylomata Acuminata;   Cervical Cancer Interventions:   Biological: HPV Vaccine,135μg/0.5ml;   Biological: HPV Vaccine,270μg/1.0ml Sponsors:   Xiamen University;   Xiamen Innovax Biotech Co., Ltd;   Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2019 Category: Research Source Type: clinical trials